Hong Kong REITS Stock News

China Coal Energy (SEHK:1898) just released its November 2025 operations update, showing coal production and sales under pressure, while ammonium nitrate output and sales jumped sharply, hinting at a quiet shift in the earnings mix. See our latest analysis for China Coal Energy. The stock has cooled off in recent weeks, with a 1 month share price return of minus 9.05 percent. However, momentum over the year still looks constructive, supported by a 1 year total shareholder return of 21.34...

Innovent Biologics (SEHK:1801) just hit a scientific milestone, with two Phase 3 trials of its dual GCG/GLP-1 drug mazdutide published back to back in Nature, sharpening the investment case around its diabetes franchise. See our latest analysis for Innovent Biologics. The latest Nature publications cap a run of positive catalysts, including NRDL additions and Hang Seng index inclusion. This comes even as the 30 day share price return of minus 7.1% contrasts with a powerful 1 year total...

Dekon Food and Agriculture Group reported that in November 2025 it sold 1,065,780 pigs, generating RMB 1,591.58 million in unaudited sales revenue. For the eleven months to November 30, 2025, the company sold 9,718,310 pigs and recorded RMB 17,524.08 million in unaudited sales, offering a detailed snapshot of its operating scale. We’ll now examine how this reported eleven‑month sales volume and revenue run-rate shapes Dekon Food and Agriculture Group’s investment narrative. Outshine the...

Alphamab Oncology recently reported that the Center for Drug Evaluation of China’s NMPA has accepted its IND application for JSKN027, an independently developed bispecific antibody-drug conjugate targeting PD-L1 and VEGFR2, paving the way for a Phase I trial in advanced solid tumors. This milestone highlights Alphamab Oncology’s push into next-generation bispecific ADCs that combine immune checkpoint blockade and anti-angiogenic mechanisms within a single molecule. We’ll now examine how the...

CARsgen Therapeutics Holdings (SEHK:2171) just checked two important boxes for investors, with zevor cel entering China’s new Innovative Drug Catalogue and fresh CT0596 data showcased at the ASH congress. See our latest analysis for CARsgen Therapeutics Holdings. Even with the share price sitting at HK$15.0 after a steep 90 day share price return of minus 28.77 percent and a softer 30 day share price return of minus 13.34 percent, the strong year to date share price return of 59.91 percent...

Beijing Enterprises Water Group has completed the issuance of RMB 1 billion in five-year 2025 Medium-term Notes Series 3 at a 2.24% annual coupon, with proceeds earmarked to repay loans from financial institutions outside Chinese Mainland. This refinancing step highlights the company’s ongoing effort to reshape its funding mix between onshore and offshore markets, which can influence its financial flexibility and interest costs. We will now examine how this onshore refinancing of offshore...

XXF Group Holdings (SEHK:2473) just moved beyond traditional auto retail by signing a long term strategic cooperation agreement with Neolix Technologies to build an unmanned vehicle services business across selected Chinese cities. See our latest analysis for XXF Group Holdings. That push into unmanned vehicle services comes after a big run, with an 84.72% year to date share price return and 85.93% one year total shareholder return, suggesting momentum is rebuilding despite a weaker 90 day...

Global hedge fund Qube Research & Technologies has agreed to lease 146,000 sq ft at MTR-owned Two International Finance Centre from 2027, becoming the tower’s largest private tenant and underscoring continued appetite for Grade A offices in Central despite earlier market softness. The deal reinforces MTR’s position as a major commercial landlord in Hong Kong’s core financial district, adding visibility to future rental income and highlighting the railway operator’s property-driven earnings...

China Ruyi Holdings (HKG:136) has had a rough three months with its share price down 22%. But if you pay close...

Hygeia Healthcare Holdings (SEHK:6078) has kicked off a sizeable share buyback after shareholders approved a mandate to repurchase up to 10% of its issued share capital, signaling a clearer commitment to shareholder returns. See our latest analysis for Hygeia Healthcare Holdings. The buyback comes after a weak stretch in the market, with the share price down sharply on a 3 year total shareholder return basis. However, the recent 7 day share price return of 9.64% suggests sentiment may be...

CK Hutchison Holdings (SEHK:1) has quietly delivered a strong run, with shares up around 32% year to date and almost 39% over the past year, prompting a closer look at what the market is now pricing in. See our latest analysis for CK Hutchison Holdings. That climb has not been a quick spike but a steady build in momentum, with a roughly 7 percent 3 month share price return feeding into a near 39 percent one year total shareholder return, as investors reassess both growth prospects and...

Earlier in December 2025, Geely Automobile Holdings Limited (SEHK:175) began a shareholder‑mandated buyback program allowing repurchases of up to 1,008,392,703 shares, equivalent to 10% of its issued share capital as of May 30, 2025, funded from legally available reserves and expected to enhance net asset value and earnings per share. At the same time, Geely’s plug‑in hybrid STARRAY EM-i SUV set a GUINNESS WORLD RECORDS™ fuel‑efficiency benchmark while its technology arm pursued tokenization...

Pop Mart’s Labubu Hangover Puts Diversification Strategy Under the Microscope Pop Mart International Group (SEHK:9992) is back in the spotlight after a steep share price slide, as investors question how long the Labubu craze can last and whether management’s diversification plans will arrive in time. See our latest analysis for Pop Mart International Group. Despite the recent pullback, including a sharp drop after the December selloff, Pop Mart’s 111.96 percent year to date share price return...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Shanxi Changcheng Microlight Equipment fair value estimate is...

This week we saw the Li Ning Company Limited ( HKG:2331 ) share price climb by 11%. But over the last three years we've...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

To the annoyance of some shareholders, Heng Tai Consumables Group Limited ( HKG:197 ) shares are down a considerable...

Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we see...

When you see that almost half of the companies in the Logistics industry in Hong Kong have price-to-sales ratios (or...

It's not a stretch to say that China Oral Industry Group Holdings Limited's ( HKG:8406 ) price-to-sales (or "P/S...

Key Insights China Golden Classic Group's estimated fair value is HK$0.091 based on 2 Stage Free Cash Flow to Equity...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...

Despite a 13% gain in Jingrui Holdings Limited's ( HKG:1862 ) stock price this week, shareholders shouldn't let up. In...